Stocks · Health care · Services-Medical Laboratories

Caris Life Sciences, Inc.

CAI Clue Score63
United States Fiscal year ends December CIK 0002019410 Results filed 4 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Brian J Brille
17 Sep 2026
See Remarks
Sold after exercise
400,000
$30.33
$12.13M
David Baxley Spetzler
4 Sep 2026
President
Sold after exercise
119,212
$24.76
$2.95M
David Baxley Spetzler
3 Sep 2026
President
Sold after exercise
84,900
$25.32
$2.15M
David Baxley Spetzler
3 Sep 2026
President
Sold after exercise
393,100
$24.76
$9.73M
Luke Thomas Power
11 Dec 2025
See Remarks
Sold after exercise
1,400
$27.16
$38.02K
Luke Thomas Power
11 Dec 2025
See Remarks
Sold after exercise
60,850
$26.56
$1.62M

What was left out

Form 4 filings counted 50
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 6
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 162,091,278
History held since 23 Jun 2025